2021 annual financial data
Mineralys Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -18,725,000 USD and net income was -19,408,000 USD.
Operating cash flow was -14,559,000 USD.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,725,000 USD
- Net income
- -19,408,000 USD
- Operating cash flow
- -14,559,000 USD